Lv1
50 积分 2023-12-18 加入
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group
1个月前
已完结
Integrating an updated high-risk multiple myeloma classification into clinical practice and clinical trial epidemiology
1个月前
已完结
Advances of next-generation STAMP inhibitors in chronic myeloid leukemia
2个月前
已完结
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study
2个月前
已完结
A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL‐321
2个月前
已完结
Pirtobrutinib is an Effective Salvage Treatment After Ibrutinib in Bing–Neel Syndrome
6个月前
已完结
Efficacy and safety of zanubrutinib combined with chimeric antigen receptor T-cell therapy targeting CD19 in refractory or relapsed diffuse large B cell lymphoma: A retrospective analysis
7个月前
已完结
Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
7个月前
已关闭
Evaluating pirtobrutinib for the treatment of relapsed or refractory mantle cell lymphoma
8个月前
已完结
Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
9个月前
已完结
双能量CT虚拟去骨图不同对比物质相对比值对膝关节创伤性骨髓水肿的诊断价值
1个月前
已采纳
皖公网安备34019202002308
